5D00.2

ICD-11 MMS 2026-01

Hereditary amyloidosis

Description

Hereditary amyloidosis (familial amyloidosis) is an inherited disorder that often affects the liver, nerves, heart and kidneys. Many different types of gene abnormalities present at birth are associated with an increased risk of amyloid disease. The type and location of an amyloid gene abnormality can affect the risk of certain complications, the age at which symptoms first appear, and the way the disease progresses over time.

Exclusions from above levels

  • 6D80 – Dementia due to Alzheimer disease
  • 2B31.2 – histiocytosis X (chronic)
  • 3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency
Show allHide
  • 5A71.01 – Congenital adrenal hyperplasia
  • 5A81.1 – 5-alpha-reductase deficiency
  • LD28.01 – Marfan syndrome
  • LD28.1 – Ehlers-Danlos syndrome
  • LD2A.4 – androgen resistance syndrome
  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

  • 5D00.20 – Hereditary ATTR amyloidosis
  • 5D00.21 – Non-neuropathic heredofamilial amyloidosis
  • 5D00.2Y – Other specified hereditary amyloidosis
  • 5D00.2Z – Hereditary amyloidosis, unspecified

Sibling codes

  • 5D00.0 – AL amyloidosis
  • 5D00.1 – AA amyloidosis
  • 5D00.3 – Dialysis-associated amyloidosis
  • 5D00.Y – Other specified amyloidosis
  • 5D00.Z – Amyloidosis, unspecified

Foundation entity

Hereditary amyloidosis – http://id.who.int/icd/entity/1152878652

Allowed postcoordination axes

Part of: 5D00: Amyloidosis › 05: Endocrine, nutritional or metabolic diseases